Market Access BIO-Europe Spring, Portugal: Propelling new wave innovation BIO-Europe Spring arrived in Lisbon, Portugal yesterday, running from 23rd to 25th March.
R&D Why it is more important than ever to optimise and innovate ... Rare disease research is vital to improve the lives of hundreds of millions of people worldwide.
R&D How the Life Sciences Innovative Manufacturing Fund can boos... Since the turn of the decade, the pharmaceuticals industry has dealt with supply chain challenges caused by both the pandemic and global conflict.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
